We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

First-Ever Serology Test Built on Multiparameter Flow Cytometry Platform Differentiates Between COVID-19 Infection and Vaccination Antibodies

By LabMedica International staff writers
Posted on 19 Jul 2021
Print article
Illustration
Illustration
A novel test can measure and track an individual's immune response to the COVID-19 vaccine, now and over time.

FlowMetric Life Sciences Inc. (Doylestown, PA, USA) has launched VaxEffect COVID-19 Vaccine Immune Response Test which will provide a personalized, and clinically accurate readout of a person's COVID-19 specific antibody levels, either generated in response to the COVID-19 vaccine or to prior exposure to the SARS-CoV-2 virus. With simple, repeat testing, changes in these antibody levels can be tracked over time utilizing easy-to-read longitudinal reports, to better inform vaccine-based healthcare decisions and to support the optimal use of booster vaccinations as they become available.

Unlike other antibody tests, VaxEffect is the first COVID serology test built on a multiparameter flow cytometry platform that is designed to differentiate between infection and vaccination based on an antibody profile. Using this proven, powerful, and precise technology, the VaxEffect Test is both 99%+ sensitive and 99%+ specific.

"The VaxEffect test will be especially important for patients with immune compromised conditions such as those fighting cancer, diabetes, auto-immune disorders, or those that are immunosuppressed due to organ transplantation, who may have not generated a strong immune response to the vaccine," said Grant Morgan, Ph.D., General Manager of VaxEffect and EVP of FlowMetric Life Sciences Inc.

Related Links:
FlowMetric Life Sciences Inc.

Gold Supplier
COVID-19 RT-PCR Kit
CoviPath COVID-19 RT-PCR Kit
New
COVID-19 ELISA Kits
COVID-19 ELISA Kits
New
L.pneumophila Assay
Uni-Gold Legionella Urinary Antigen PLUS
New
Electrolyte Analyzer
PLK1000 Electrolyte Analyzer

Print article

Channels

Molecular Diagnostics

view channel
Image: Primary angle closure glaucoma can cause permanent blindness if not treated quickly. A highly sensitive genetic test has been developed (Photo courtesy of Flinders University)

Highly Sensitive Genetic Test for Glaucoma Developed

In open-angle glaucoma, the angle in the eye where the iris meets the cornea is as wide and open as it should be, but the eye’s drainage canals become clogged over time, causing an increase in internal... Read more

Industry

view channel
Illustration

ELITechGroup Acquires Freezing Point Osmometry Provider GONOTEC

ELITechGroup (Puteaux, France) has acquired GONOTEC (Berlin, Germany), thus uniting two osmometry market leaders. The acquisition will also provides the industry with a full range of osmometry solutions... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.